UK’s first baby born with genes from three persons in new IVF method; Details here

A groundbreaking IVF procedure has been successfully performed in the UK, resulting in the birth of the first baby with genetic material from three persons. This innovative technique aims to prevent the transmission of incurable diseases to children.

Mitochondrial donation treatment (MDT), a technique utilized in this process, involves using tissue from healthy female donors' eggs to generate IVF embryos that are devoid of the harmful mutations carried by the mothers. These mutations would otherwise be transmitted to their offspring.

Due to the incorporation of mitochondria from the donor's egg, the embryos created in this procedure contain 99.8% genetic material from both the biological mother and father, along with a remaining portion of genetic material, from the donor.


The term "three-parent babies" has been associated with this process, although over 99.8% of the babies' DNA still originates from their biological mother and father.

The development of MDT, also referred to as mitochondrial replacement therapy (MRT), was pioneered by doctors at the Newcastle Fertility Centre in the UK. The primary objective of their research was to assist women with mutated mitochondria in having children without the risk of transmitting genetic disorders. Since individuals inherit all their mitochondria from their mother, mutations in these "batteries" can impact all the children a woman bears.

Prior to the UK's achievement, another country had already succeeded in creating babies using MDT. In 2016, a Jordanian family undergoing treatment in the United States became the first to have a baby born through this technique.

FAQs:

Q1:Where was the first baby born with genes from 3 people?
In 2016, a Jordanian family undergoing treatment in the United States became the first to have a baby born through the MDT technique in which genes from three persons is utilised.

Q2:What is MDT?
Mitochondrial donation treatment (MDT), a technique utilized in this process, involves using tissue from healthy female donors' eggs to generate IVF embryos that are devoid of the harmful mutations carried by the mothers. These mutations would otherwise be transmitted to their offspring.